Economics of bladder cancer

Bishoy A. Gayed, Yair Lotan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Bladder cancer carries a significant economic burden to overall healthcare costs. More cost-effective measures are needed to help alleviate the financial strain of bladder cancer. Novel approaches that reduce disease recurrence and progression, and limit severity of complications are imperative to aid with cost containment. Further research evaluating the use of urinebasedmarkers improved cystoscopy, adjuvant therapies and cost-effective surveillance protocolsmay be feasible options to lessen the costs associated with bladder cancer

Original languageEnglish (US)
Title of host publicationAdvances in Bladder Cancer Management
PublisherFuture Medicine Ltd.
Pages90-102
Number of pages13
ISBN (Print)9781780844237, 9781780844251
DOIs
Publication statusPublished - Oct 1 2015

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gayed, B. A., & Lotan, Y. (2015). Economics of bladder cancer. In Advances in Bladder Cancer Management (pp. 90-102). Future Medicine Ltd.. https://doi.org/10.2217/fmeb2013.13.2